Owings Mills, Md. - (August 31, 2009) - Clinical Trials & Surveys Corp. (C-TASC), a clinical trials solutions company, announced today that it has implemented new technology to make raw and processed gene data available online for use by investigators in clinical research. The new capability allows C-TASC to accept gene data in either raw or processed format, upload it to its StudyCTMSTM database through an automated process and make it available for anyone conducting research to search and request.

This new service is offered as part of C-TASC's Biorepository Management System, StudyBRMS, which streamlines the procedures of collecting, processing, storing and distributing images and specimens to support clinical studies. C-TASC currently manages national biorepositories, including the National Heart Lung and Blood Institute's (NHLBI) Lung Tissue Research Consortium (LTRC). The LTRC is one of the nation's largest collections of tissue and medical data available for researchers to search and request samples for analysis through the Web site www.ltrcpublic.com. Now, in addition to tissue samples, scans and clinical data, the subjects' anonymized raw and processed gene data will also be available, allowing investigators to expand upon their research.

"As clinical research trends more towards personalized medicine, the clinical trials and studies of the future will require genetic data. This technology provides a linkage between clinical data, gene data, specimens and images allowing the user to run queries on subject populations and complete online requests for all materials required for their research," said Dr. Bruce Thompson, president, C-TASC. "Any investigator that wants to utilize gene data as a part of their clinical trials and studies will benefit from this new feature that makes subject gene data as easily accessible online as physical specimens and clinical data."

C-TASC specializes in providing Web-based technology solutions that enable researchers to develop and manage trials that deliver FDA-acceptable results more efficiently and affordably. C-TASC's StudyBRMS solution is a module of the company's proprietary clinical trial management system, StudyCTMSTM, which is planned for public launch this fall.

About C-TASC
Based near Baltimore, Clinical Trials & Surveys Corp. (C-TASC) is a clinical trials solutions company that has supported best practices management of clinical trials and studies for government, university and private organizations since 1989. C-TASC has a successful research history in cancer, cardiovascular disease, AIDS, pulmonary disease, Cystic Fibrosis, sleep disorders and pharmaco-epidemiology. C-TASC's software group utilizes the firm's StudyCTMSTM product suite to provide investigators with complete Web-based trial management designed to deliver FDA-acceptable data. The C-TASC professional services group provides expert consultation in all areas of clinical trial management including medical and statistical study design, project management, data conversion including FDA SDTM formatting, performance monitoring, data quality control and analysis as well as support for study publication and presentation. For more information about C-TASC's projects, products and services, please visit
www.c-tasc.com.